Home/Filings/4/0000950170-25-050470
4//SEC Filing

DEMANE MICHAEL F 4

Accession 0000950170-25-050470

CIK 0001444380other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:30 PM ET

Size

10.9 KB

Accession

0000950170-25-050470

Insider Transaction Report

Form 4
Period: 2025-04-03
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2025-04-03164,3440 total(indirect: See footnote)
  • Disposition to Issuer

    Common Stock

    2025-04-0361,8630 total
  • Disposition to Issuer

    Common Stock

    2025-04-03219,1450 total(indirect: See footnote)
  • Disposition to Issuer

    Common Stock

    2025-04-0358,2660 total(indirect: See footnote)
Footnotes (5)
  • [F1]Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time").
  • [F2]At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration.
  • [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
  • [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
  • [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane,Trustees, Michael F. DeMane Revocable Trust 10/07/2011.

Documents

1 file

Issuer

NEVRO CORP

CIK 0001444380

Entity typeother

Related Parties

1
  • filerCIK 0001174533

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
10.9 KB